Locally Advanced Rectal Cancer - Radiation Response Prediction
- Prosjektnummer
- 2008135
- Ansvarlig person
- A.H.Ree/S.Dueland/K.Flatmark
- Institusjon
- Oslo universitetssykehus HF - Rikshospitalet
- Prosjektkategori
- Nytt flerårig forskningsprosjekt
- Helsekategori
- Cancer
- Forskningsaktivitet
- 5. Treatment Developement
Preoperative radiotherapy in rectal signet-ring cell carcinoma - magnetic resonance imaging and treatment outcome: Report of six cases.
Acta Oncol 2010;49(1):42-9.
PMID: 20100143
Prediction of response to preoperative chemoradiotherapy in rectal cancer by multiplex kinase activity profiling.
Int J Radiat Oncol Biol Phys 2010 Oct;78(2):555-62. Epub 2010 aug 2
PMID: 20675069
Radiosensitizing drugs: lessons to be learned from the oxaliplatin story.
J Clin Oncol 2010 Oct;28(29):e577-8; author reply e581-3. Epub 2010 aug 23
PMID: 20733124
MR-guided simultaneous integrated boost in preoperative radiotherapy of locally advanced rectal cancer following neoadjuvant chemotherapy.
Radiother Oncol 2009 Nov;93(2):279-84. Epub 2009 okt 1
PMID: 19800704
Principal component analysis for the comparison of metabolic profiles from human rectal cancer biopsies and colorectal xenografts using high-resolution magic angle spinning 1H magnetic resonance spectroscopy.
Mol Cancer 2008;7():33. Epub 2008 apr 25
PMID: 18439252
Inhibitory effects of oxaliplatin in experimental radiation treatment of colorectal carcinoma: does oxaliplatin improve 5-fluorouracil-dependent radiosensitivity?
Radiother Oncol 2008 Mar;86(3):428-34. Epub 2007 nov 19
PMID: 18006097
HDAC2 deficiency and histone acetylation.
Nat Genet 2008 Jul;40(7):812-3; author reply 813.
PMID: 18583969
Experimental Radiosensitization and Molecular Prediction of Chemoradiotherapy Response in Rectal Cancer
- Disputert:
- oktober 2009
- Hovedveileder:
- Anne Hansen Ree
Magnetic resonance spectroscopy and diffusion for prediction and monitoring of treatment response in rectal cancer
- Disputert:
- mars 2008
- Hovedveileder:
- Dag Rune Olsen
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til eRapport